De-escalating and discontinuing disease-modifying therapies in multiple sclerosis - Top-Institutions - MDSpire

De-escalating and discontinuing disease-modifying therapies in multiple sclerosis

  • By

  • Géraldine Androdias

  • Jan D Lünemann

  • Elisabeth Maillart

  • Maria Pia Amato

  • Bertrand Audoin

  • Arlette L Bruijstens

  • Gabriel Bsteh

  • Helmut Butzkueven

  • Olga Ciccarelli

  • Alvaro Cobo-Calvo

  • Tobias Derfuss

  • Franziska Di Pauli

  • Gilles Edan

  • Christian Enzinger

  • Ruth Geraldes

  • Cristina Granziera

  • Yael Hacohen

  • Hans-Peter Hartung

  • Sinéad Hynes

  • Matilde Inglese

  • Ludwig Kappos

  • Hanna Kuusisto

  • Annette Langer-Gould

  • Melinda Magyari

  • Romain Marignier

  • Xavier Montalban

  • Marcin P Mycko

  • Bardia Nourbakhsh

  • Jiwon Oh

  • Celia Oreja-Guevara

  • Fredrik Piehl

  • Luca Prosperini

  • Jaume Sastre-Garriga

  • Finn Sellebjerg

  • Krzysztof Selmaj

  • Aksel Siva

  • Emma Tallantyre

  • Vincent van Pesch

  • Sandra Vukusic

  • Bianca Weinstock-Guttman

  • Frauke Zipp

  • Mar Tintoré

  • Ellen Iacobaeus

  • Bruno Stankoff

  • December 21, 2024

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research
    Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #2

    Brigham and Women's Hospital - Partners MS Center
    Brigham and Women's Hospital - Partners MS Center

    Boston, MA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #3

    University of California, San Francisco (UCSF) Multiple Sclerosis Center
    University of California, San Francisco (UCSF) Multiple Sclerosis Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #4

    Karolinska Institutet - Neuroimmunology and Multiple Sclerosis Research
    Karolinska Institutet - Neuroimmunology and Multiple Sclerosis Research

    Stockholm, Stockholm County

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #5

    University of Oxford - Nuffield Department of Clinical Neurosciences
    University of Oxford - Nuffield Department of Clinical Neurosciences

    Oxford, Oxfordshire

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

Original Source(s)

De-escalating and discontinuing disease-modifying therapies in multiple sclerosis

  • by Géraldine Androdias, Jan D Lünemann, Elisabeth Maillart, Maria Pia Amato, Bertrand Audoin, Arlette L Bruijstens, Gabriel Bsteh, Helmut Butzkueven, Olga Ciccarelli, Alvaro Cobo-Calvo, Tobias Derfuss, Franziska Di Pauli, Gilles Edan, Christian Enzinger, Ruth Geraldes, Cristina Granziera, Yael Hacohen, Hans-Peter Hartung, Sinéad Hynes, Matilde Inglese, Ludwig Kappos, Hanna Kuusisto, Annette Langer-Gould, Melinda Magyari, Romain Marignier, Xavier Montalban, Marcin P Mycko, Bardia Nourbakhsh, Jiwon Oh, Celia Oreja-Guevara, Fredrik Piehl, Luca Prosperini, Jaume Sastre-Garriga, Finn Sellebjerg, Krzysztof Selmaj, Aksel Siva, Emma Tallantyre, Vincent van Pesch, Sandra Vukusic, Bianca Weinstock-Guttman, Frauke Zipp, Mar Tintoré, Ellen Iacobaeus, Bruno Stankoff

  • December 21, 2024

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

Marcus Neuroscience Institute, part of Baptist Health South Florida, will host its two-day 2026 Brain & Spine Symposium on May 14 and 15.

  • by

  • April 6, 2026

  • 3 min
Rule-based semi-automated method to segment black hole multiple sclerosis lesions on post-gadolinium 2D T1-weighted brain images